echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > These 20 drugs sell best (with list)

    These 20 drugs sell best (with list)

    • Last Update: 2021-01-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, Fujian Sunshine purchase drug sales amount Top20 announced 1, drug sales amount Top20 announced January 8, Fujian Provincial Health Insurance Bureau issued 8, 9, 10, 11, 4 months of Sunshine purchase drug sales amount ranked in the top 20 list.
    , the list doesn't change much, so let's take a look at the latest drug sales, Top20.
    drugs that have entered the "Fujian Province Drug Joint Price Limit Sunshine Purchase Drug Sales Amount Ranking 20 (November 2020)" list are: injection cephalosporine sodium Shubatan sodium, methylfate oxytide Nipple tablets, cephalosporine for injection, inhalation with Budinide mixed suspension, nitrobenzene flat-control release tablets, injection with curly bead monoanti, phosphate segritin tablets, amber acid metolor slow release tablets Insulin glycerine injections, devasalban tablets, pyrothrome chloride tablets (I.), injection cephalosporine sodium, hydrochlorocarbon grease tablets, tekmos capsules, atovastatin calcium tablets, injection of acetic acid bright propylene micro-balls, Budined fumotro inhalation powder mist (II.), beva bead monoantigen injection, injection of melopion.
    2, head varieties, foreign enterprises divided into according to Saibai Blue combing, ranked in Fujian Province sales amount top20 drugs only 3 from domestic pharmaceutical companies, respectively, North China Pharmaceuticals Hebei Huamin Pharmaceuticals injection cephalosporine loss sodium, Shenzhen Xinlitai's hydrochlorochloride tablets, Jiangsu Hengrui Pharmaceutical injection with yew alcohol (white protein binding type).
    The rest of the drugs come from large multinational pharmaceutical companies, such as Pfizer, AstraZenetel, Bayer, Roche, Mercedon, Sanofi, Novarma, Astellas, Takeda, Japan's HomeIta, etc. - of which Pfizer, AstraZeneta and Roche have more drugs on the list.
    for Fujian Pharmaceutical Sunshine procurement top20 foreign-owned products mainly the situation, before, Mi Net has had the relevant statistics - Fujian Province drug procurement platform 22 months of drug sales amount TOP20, a total of 440 drugs (in the name of drugs plus The statistical results show that 296 of the 440 drugs are products of multinational pharmaceutical companies, accounting for 67.26 percent, and 144 are domestic drugs, accounting for 32.74 percent.
    specifically, in November 2020, Fujian Province drug sales amount top20, Pfizer has two varieties on the list, namely, injection of cephalosporine sodium shubatan sodium, atovastatin calcium tablets; Hetini tablets, inhaled buprene mixed suspensions, amber acid metolor slow release tablets, Budinaid fumotro inhaled powder mist (II.); Roche also has two heavy varieties on the list, are injectable clove bead monoantigen and beval bead monoantigen.
    Overall, from the Top20 list, cardiovascular drugs, systemic anti-infective drugs, anti-tumor drugs, respiratory drugs and immunomodulators and other drugs to treat common chronic diseases, Fujian public medical institutions are the main drugs.
    3, the impact of policy effects is noteworthy, due to the large clinical use of drugs on the list, the use of high amounts, many of which have been included in the national and local organizations of drug collection.
    Atovastatin, clopidogrel, injection of yew alcohol albumin, prostatin ammonia chloride tablets (I.) are all nationally organized drug collection varieties, and the trend of local collection of antibiotics and injection forms is also very obvious.
    Under the influence of the national organization's drug collection, the varieties on the list have also changed - in terms of hydrochlorocarbon tablets of sulphate, Sanofi's hydrochlorochloride and Lepu's hydrochlorochlorocarpharide are both on the list in the past, but due to Reliantai In the first round of 4 plus 7 band procurement successfully selected hydrochlorochlorocarbon gray sulfate, since Fujian Province after the implementation of 4 plus 7, the original research drugs and uncontested products fell out of TOP20, Xinlitai by virtue of the winning bid advantage, for many months in a row on the list.
    In addition to volume purchases, the impact of health insurance on the list is also evident - combined with Fujian Province's previous sales list, 15 anti-tumor drugs, including Roche, have been negotiated into the national health insurance list since 2017. The "troika" - Lytoxi mono-resistance, quercturous bead mono-resistance and beva-bead mono-resistance have ushered in different degrees of release, injection of quercturous bead mono-resistance even once ranked first in Fujian drug sales amount TOP20.
    in the latest list, the injection of curly bead monoantial resistance remains high in sixth place.
    20 (November 2020) in Fujian Sunshine, China
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.